ArticleAdvances in experimental medicine and biology2026
Time-Dependent Efficacy of Drag-Reducing Polymers in the Treatment of Permanent Middle Cerebral Artery Occlusion Injury in Rats.
Article in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Current treatments for ischemic stroke are not focused on microvascular cerebral blood flow (mvCBF), which actually delivers oxygen to tissue and is significantly impaired during a stroke. We previously showed that drag-reducing polymers (DRPs, 2 μg/ml), injected just after permanent middle cerebral artery occlusion (pMCAO) in rats, effectively restored mvCBF and tissue oxygenation. The aim of this work was to assess the efficiency of DRPs administered at various time points post-onset. DRPs (2 μg/ml) or saline was i.v. injected 0.5, 3, or 6 h after pMCAO induction in rats (n = 10/group). Laser speckle contrast imaging (LSCI) was used to evaluate regional cerebral blood flow in the parietal cortex and estimate the ischemic area. In vivo 2-photon laser scanning microscopy (2PLSM) was used to assess the effects on mvCBF and tissue hypoxia (NADH). Two-way ANOVA for multiple comparisons was used to test intergroup differences with the statistical significance level set at p < 0.05. PMCAO progressively decreased cortical mvCBF, causing tissue hypoxia (p < 0.05). Intravenous administration of DRPs at 0.5, 3, and 6 h post-pMCAO effectively improved cerebral microcirculation and oxygen delivery to tissue in a time-dependent manner compared to the saline-treated group (p < 0.05). DRPs efficacy reduced with the time of application from 0.5 to 6 h after pMCAO but remained significant compared to the saline-treated group (p < 0.05). DRPs augment collateral microcirculatory flow through leptomeningeal and pial anastomoses that interconnect the middle, anterior, and posterior cerebral artery watershed territories. We demonstrated that DRPs can be used as a new effective adjunct therapy for ischemic stroke, even without reperfusion and after delayed administration following the stroke onset.
Indexed as
Identifiers
41577920What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.